Topical Webminar: Photon imaging technologies for nuclear medicine therapy

by Dr. Javier Caravaca Rodríguez (Lawrence Berkeley National Laboratory, USA)

Tuesday 10 Sep 2024, 17:00 → 18:00 Europe/Madrid

1001-Primera-1-1-1 - Paterna. Seminario (Universe)

The combination of radionuclide therapy with diagnostics (or theranostics) enables personalized radionuclide therapy, resulting in much more precise, effective, and less toxic treatments. In-vivo clinical and preclinical imaging of these radionuclides is critical for the success of theranostics. In the last decade, single photon emission computed tomography or SPECT has shown excellent performance imaging non-therapeutical radiotracers, but it presents serious limitations when imaging therapeutical radionuclides due to its relatively low sensitivity. I will review the research portfolio and recent results of the Particle Research Laboratory at UCSF towards imaging of challenging theranostics radionuclides like 225Ac and 177Lu for preclinical and clinical purposes. This includes development of non-standard SPECT concepts using Compton and proximity imaging.

 

Link to the recorded colloquium